Slate Path Capital LP — insider trades

Stock trades Slate Path Capital LP reported on SEC Form 4 at CYCN Cyclerion Therapeutics, Inc..

• Nov 21, 2024: sold 357,880 shares of CYCN Cyclerion Therapeutics, Inc. ($555K)